1-9 of 9
Sheryl M Gough
Close
Sort by
Journal Articles

Potent and Orally Bioavailable BCL6 PROTAC TM Degraders Demonstrate Efficacy in Pre-Clinical Models of Diffuse Large B-Cell Lymphoma (DLBCL)

Sheryl M Gough, Dan Sherman, Lynn DeCarr, Sarah Eaton, Maja Milanovic, Mark Bookbinder, Jennifer Pizzano, Martha Altieri, John Corradi, Hong Xiao, Felipe Gallego, Leofal Soto, Ram Lingamaneni, Xin Chen, Wei Zhang, Gan Wang, Hanqing Dong, Deborah Chirnomas, Michael Berlin, Keith Hornberger, Lawrence Snyder, Ian Taylor
Journal: Blood
Blood (2021) 138 (Supplement 1): 2272.
https://doi.org/10.1182/blood-2021-149654
Published: 2021
Journal Articles

Spontaneous Mutations of Bcor and Jak1/2 genes Lead to an Aggressive Leukemia of B-1 Progenitor B Cells

Sheryl M Gough, PhD BSc, Liat Goldberg, PhD, Marbin Pineda, MS, Robert L Walker, BSc, Yuelin J Zhu, MD MSc, Sven Bilke, PhD, Paul S Meltzer, MD PhD, Peter D Aplan, MD
Journal: Blood
Blood (2014) 124 (21): 3573.
https://doi.org/10.1182/blood.V124.21.3573.3573
Published: 2014
Journal Articles

Leukemia Driven By a NUP98-Phd Domain Fusion Is Highly Sensitive To Disruption Of H3K4me3-Phd Domain Binding By a Small Molecule Inhibitor

Sheryl M Gough, PhD, Fan Lee, BS, Robert L Walker, BSc, Fan Yang, PhD, Yuelin Zhu, MD, Marbin Pineda, MS, Masahiro Onozawa, MD, PhD., Yang Jo Chung, PhD, Sven Bilke, PhD, Elise K Wagner, PhD, John M Denu, PhD, Yi Ning, MD, PhD, Paul S Meltzer, MD, PhD, Peter D Aplan, MD
Journal: Blood
Blood (2013) 122 (21): 3759.
https://doi.org/10.1182/blood.V122.21.3759.3759
Published: 2013
Journal Articles

Illegitimate V(D)J Recombination Involving Notch1 and Bcl11b in Precursor T-Cell Lymphoblastic Leukemia/Lymphoma

Masahiro Onozawa, MD, PhD., Hyunkyung Kim, MD, PhD., Sheryl M Gough, BSc, PhD, Yingwei Lin, MD., PhD., Yongzhi Cui, MD, PhD., Sarah H Beachy, PhD, Crystal L Mackall, MD, Peter Aplan, MD
Journal: Blood
Blood (2012) 120 (21): 1323.
https://doi.org/10.1182/blood.V120.21.1323.1323
Published: 2012
Journal Articles

Mice with Myelodysplastic Syndrome Respond to Treatment with Azanucleosides: A Preclinical Model for MDS Therapies

Sheryl M Gough, PhD, Yang Jo Chung, PhD, Maegawa Shinji, PhD, Jaroslav Jelinek, MD, PhD, Jean-Pierre Issa, MD, Peter Aplan, MD
Journal: Blood
Blood (2012) 120 (21): 3829.
https://doi.org/10.1182/blood.V120.21.3829.3829
Published: 2012
Journal Articles

NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights

Sheryl M. Gough, Christopher I. Slape, Peter D. Aplan
Journal: Blood
Blood (2011) 118 (24): 6247–6257.
https://doi.org/10.1182/blood-2011-07-328880
Published: 2011
Journal Articles

A NUP98-PHF23 Transgenic Mouse Model Develops AML and T-ALL

Sheryl M Gough, PhD, Fan Lee, BSc, Yang Jo Chung, PhD, Robert L Walker, BSc, Fan Yang, PhD, Yuelin (Jack) Zhu, MD, MSc, Yi Ning, PhD, Paul S Meltzer, MD, PhD, Peter Aplan, MD
Journal: Blood
Blood (2011) 118 (21): 2467.
https://doi.org/10.1182/blood.V118.21.2467.2467
Published: 2011
Journal Articles

Increased Mutation Frequency Induced by Oxidative Stress in the NUP98-HOXD13 MDS Mouse Model

Yang Jo Chung, PhD, Carine Robert, PhD, Sheryl M Gough, BSc, PhD, Feyruz Rassool, PhD, Peter Aplan, MD
Journal: Blood
Blood (2011) 118 (21): 1705.
https://doi.org/10.1182/blood.V118.21.1705.1705
Published: 2011
Journal Articles

Rag1 Deficiency Does Not Affect Myelodysplasia but Leads to More Rapid Leukemic Transformation in a Mouse Model of MDS.

Sheryl M Gough, PhD, Yang Jo Chung, PhD, Peter D. Aplan, MD
Journal: Blood
Blood (2009) 114 (22): 2784.
https://doi.org/10.1182/blood.V114.22.2784.2784
Published: 2009